Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view).
Shares of Moderna are up 0.75% at $183.47. The company is worth $73.25B, number 227 out of 300 on our list.
Over the past 52 weeks it has traded between $22.28 and $192.31, so it sits 4.6% below the top of that range. Holders are ahead 608.9% over twelve months, and up 203.7% across the last three months.
On the chart it holds above both the 50-day ($104.93) and 200-day ($62.58) moving averages; RSI is 73, which some call overbought, and the last 30 sessions moved at roughly 316% annualized volatility.
In the quarter ended Jun 2026 the company brought in $143.00M of revenue, up 4.4% from a year earlier, and a net loss of $782.00M.
13 analysts follow the stock and the average call is "hold". The mean target, $113.40, sits 38.2% under where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Moderna develops vaccines and treatments based on mRNA technology, and became known for its COVID-19 vaccine.
What tends to move it. Declining COVID vaccine sales, cost cuts and the outcome of flu and cancer vaccine trials shape the stock, and it burns cash.
Written by hand by the BeStock desk and revised when a business changes. See how we work. Spot something out of date? Tell us.
Price return over each window, from adjusted daily and weekly closes
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | +21.7% | Bullish |
| Price vs 50-day average | +74.8% | Bullish |
| Price vs 200-day average | +193.2% | Bullish |
| 50-day vs 200-day | 50d above 200d | Bullish |
| RSI (14) | 72.9 | Neutral |
| MACD (12,26,9) | 18.28 | Bullish |
| Bollinger band position | 108% | Neutral |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Quote as of Sep 24, 2026 1:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 300 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A row is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Latest reported quarter: Q2, ended Jun 2026
Quarter 2026/Q2
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 1st percentile, 5-year average 2.2x
Near the top of its 5-year range · 93rd percentile, 5-year average 3.6x
#4755 of 5304 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 99th percentile, 5-year average 5.7x
#4721 of 5143 stocks by PS (1 = cheapest)
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Who holds it, who is betting against it, and where the big money is moving
Net of large-order buying minus selling, in USD. Over this window: +$224.21M (9 inflow days, 11 outflow days).
$183.47 is the latest print for MRNA, a move of +0.75% against yesterday's close of $182.11. Today's low and high so far: $180.39 and $189.22.
Equity value comes to $73.25B at the current price. By that measure it is number 227 of the 300 names in our coverage.
The year's floor is $22.28 and the ceiling $192.31. Shares are 4.6% away from that ceiling.
Our data shows no dividend paid by Moderna over the trailing twelve months.
Of 13 analysts, 23% say buy, 62% hold and 15% sell. Price targets average $113.40, with the most cautious at $60.00 and the most optimistic at $180.00.
Moderna develops vaccines and treatments based on mRNA technology, and became known for its COVID-19 vaccine.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.